Advanced search
Publication Cover
International Journal of Women's Health Volume 12, 2020 - Issue
Submit an article Journal homepage
553
Views
4
CrossRef citations to date
0
Altmetric
Review

Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review

Yang Yang1 University of Manitoba, Winnipeg, MB, CanadaORCID Iconhttps://orcid.org/0000-0003-0873-6234
ORCID Icon,
Isabelle Boucoiran2 Department of Obstetrics & Gynecology, Université de Montréal, Montreal, QC, CanadaORCID Iconhttps://orcid.org/0000-0001-9545-6024
ORCID Icon,
Karen J Tulloch3 BC Women’s Hospital, Vancouver, BC, Canada
&
Vanessa Poliquin4 Department of Obstetrics & Gynecology, University of Manitoba, Winnipeg, MB, CanadaCorrespondence[email protected]
Pages 159-170 | Published online: 09 Mar 2020

References

  • Spitz AM, Lee NC, Peterson HB. Treatment for lactation suppression Little progress in one hundred years. Am J Obstet Gynecol. 1998;179(6):1485–1490. doi:10.1016/S0002-9378(98)70013-4
  • Gionet L. Health at a Glance - Breastfeeding trends in Canada. November 2015.
  • Schanler RJ, Potak DC. Physiology of lactation. UpToDate.
  • Oladapo OT, Fawole B. Treatments for suppression of lactation. Cochrane Database Syst Rev. 2012;(9):Art.No.: CD005937. doi:10.1002/14651858.CD005937.pub2
  • Snellen M, Power J, Blankley G, Galbally M. Pharmacological lactation suppression with D2 receptor agonists and risk of postpartum psychosis: A systematic review. Aust N Z J Obstet Gynaecol. 2016;56:336–340. doi:10.1111/ajo.12479
  • Money D, Tulloch K, Boucoiran I, Caddy S. Guidelines for the care of pregnant women living with HIV and interventions to reduce perinatal transmission: executive summary. J Obstet Gynaecol Can. 2014;36(8):721–734. doi:10.1016/S1701-2163(15)30515-6
  • Centers for Disease Control and Prevention. HIV among pregnant women, infants, and children. Available from: https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html. Accessed October 1, 2018.
  • Gilleece Y. British HIV Association guidelines for the management of HIV infection in pregnant women 2018. HIV Med. 2012;13:87–157. doi:10.1111/j.1468-1293.2012.01030.x
  • ROG. Late Intrauterine Fetal Death and Stillbirth Green-top Guideline No. 55.
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration; 2011. Available from: www.handbook.cochrane.org. Accessed February 18, 2020.
  • European Multicentre Study Group for Cabergoline in Lactation Inhibition. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. BMJ. 1991;302:1367–1371.
  • Caballero-Gordo A, Lopez-Nazareno N, Calderay M, Caballero J, Mancheño E, Sghedoni D. Oral cabergoline. Single-dose inhibition of puerperal lactation. J Reprod Med. 1991;36:717–721.
  • Nisha SU, Sachan V, Sankhwar P. Role of newer drug cabergoline in lactation suppression as compared to estrogen-androgen combination. J Obstet Gynaecol India. 2009;152–155.
  • Giorda G, Vincentiis S, Motta T, Casazza S, Fadin M, D’Alberton A. Cabergoline vs bromocriptine in suppression of lactation after Cesarean delivery. Gynecol Obstet Invest. 1991;31:93–96. doi:10.1159/000293109
  • Melis GB, Gambacciani M, Paoletti AM. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women. J Clin Endocrinol Metab. 1987;65:541–545. doi:10.1210/jcem-65-3-541
  • Melis G, Mais V, Paoletti A, Beneventi F, Gambacciani M, Fioretti P. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline. Obstet Gynecol. 1988;71:311–314.
  • Gupta P, Tundup T, Singh J. Treatment complexities in psychosis associated with cabergoline treatment in patients having pituitary prolactinomas. Asian J Psychiatry. 2018;31(1):129–132. doi:10.1016/j.ajp.2018.01.011
  • Buhendwa L, Zachariah R, Teck R, et al. Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi. Trop Doct. 2008;38:30–32. doi:10.1258/td.2007.060091

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.